Literature DB >> 20978756

FDG-PET/CT imaging of elastofibroma dorsi.

Yumiko Onishi1, Kazuhiro Kitajima, Michio Senda, Setsu Sakamoto, Kayo Suzuki, Tetsuo Maeda, Takeshi Yoshikawa, Yoshiharu Ohno, Kazuro Sugimura.   

Abstract

OBJECTIVE: The purpose of this study was to assess retrospectively the characteristics of FDG uptake in elastofibroma dorsi using integrated PET/CT.
METHODS: From 10,261 oncology FDG-PET/CT scans performed over a 2-year period, findings suggestive of elastofiboma dorsi were observed in 46 FDG-PET/CT scans of 34 patients. As 20 patients had bilateral lesions and 14 had unilateral lesions, a total of 75 elastofibroma dorsi lesions on images were identified in this study. For visual analysis of intensity of FDG uptake , a four-point grading system was used: grade 0 for no uptake, grade 1 for less uptake than the liver, grade 2 for uptake comparable to the liver, and grade 3 for intense uptake greater than the liver. For quantitative analysis, the standardized uptake value (SUV) was calculated. The relationships between SUV and age, blood glucose level, lesion size, and related symptoms were also assessed.
RESULTS: Among the 75 lesions, 4 had an uptake grade of 0, 41 had grade 1, 25 had grade 2, and 5 had grade 3. The mean SUV (±SD) of the 75 lesions was 2.0 ± 0.63 (range 0-5.1). The Pearson correlation coefficient test indicated a weak positive correlation between SUV and lesion size and no correlation between SUV and either age or blood glucose level. The SUVs of patients with symptoms due to the disease and patients without symptoms were almost the same.
CONCLUSION: Mild and moderate uptake of FDG is frequently observed in elastofibroma dorsi, which should not be misinterpreted as abnormal accumulation observed in malignant lesions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20978756     DOI: 10.1007/s00256-010-1057-3

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  12 in total

Review 1.  Atypical appearance of elastofibroma dorsi on MRI: case reports and review of the literature.

Authors:  S Schick; A Zembsch; A Gahleitner; P Wanderbaldinger; G Amann; M Breitenseher; S Trattnig
Journal:  J Comput Assist Tomogr       Date:  2000 Mar-Apr       Impact factor: 1.826

2.  Hypermetabolism of elastofibroma dorsi on PET-CT.

Authors:  Jerome C Pierce; Robert Henderson
Journal:  AJR Am J Roentgenol       Date:  2004-07       Impact factor: 3.959

3.  Elastofibroma dorsi: A report on 6 cases.

Authors:  Seddik Oueslati; Wiem Douira-Khomsi; Mouna Chelli Bouaziz; Khalil Zaouia
Journal:  Acta Orthop Belg       Date:  2006-04       Impact factor: 0.500

4.  Imaging patterns in elastofibroma dorsi.

Authors:  M Battaglia; D Vanel; P Pollastri; A Balladelli; M Alberghini; E L Staals; C Monti; S Galletti
Journal:  Eur J Radiol       Date:  2009-06-17       Impact factor: 3.528

5.  Incidental detection of bilateral elastofibroma dorsi with F-18 FDG PET/CT.

Authors:  Christopher W Wasyliw; Vicente J Caride
Journal:  Clin Nucl Med       Date:  2005-10       Impact factor: 7.794

6.  Elastofibroma dorsi: radiologic findings in 12 patients.

Authors:  M F Naylor; A G Nascimento; A D Sherrick; R A McLeod
Journal:  AJR Am J Roentgenol       Date:  1996-09       Impact factor: 3.959

7.  Subclinical elastofibromas in the scapular region in an autopsy series.

Authors:  O H Järvi; P H Länsimies
Journal:  Acta Pathol Microbiol Scand A       Date:  1975-01

8.  Elastofibroma in Okinawa. A clinicopathologic study of 170 cases.

Authors:  N Nagamine; Y Nohara; E Ito
Journal:  Cancer       Date:  1982-11-01       Impact factor: 6.860

Review 9.  Elastofibroma dorsi--a case report and review of literature.

Authors:  A R Guha; R C S Raja; V G Devadoss
Journal:  Int J Clin Pract       Date:  2004-02       Impact factor: 2.503

10.  Elastofibroma dorsi: 8 case reports and a literature review.

Authors:  F Muratori; M Esposito; F Rosa; F Liuzza; N Magarelli; B Rossi; H M Folath; F Pacelli; G Maccauro
Journal:  J Orthop Traumatol       Date:  2008-03-13
View more
  8 in total

Review 1.  Musculoskeletal tumors and tumor-like conditions: common and avoidable pitfalls at imaging in patients with known or suspected cancer: Part A: benign conditions that may mimic malignancy.

Authors:  Gary Ulaner; Sinchun Hwang; Robert A Lefkowitz; Jonathan Landa; David M Panicek
Journal:  Int Orthop       Date:  2013-02-23       Impact factor: 3.075

2.  Elastofibroma dorsi.

Authors:  Pradeep Goyal; Darshan Gandhi; Sonali Gupta; Shuo Li; Yogesh Kumar; Thomas D Olsavsky; Nishant Gupta
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-07

Review 3.  PET-CT in Clinical Adult Oncology: II. Primary Thoracic and Breast Malignancies.

Authors:  Matthew F Covington; Bhasker R Koppula; Gabriel C Fine; Ahmed Ebada Salem; Richard H Wiggins; John M Hoffman; Kathryn A Morton
Journal:  Cancers (Basel)       Date:  2022-05-29       Impact factor: 6.575

4.  Concomitant bilateral elastofibroma in the infrascapular and gluteal regions: a report of a rare case.

Authors:  Omran Al Dandan; Ali Hassan; Mona Al Muhaish; Jumanah AlMatrouk; Haidar Almuhanna; Tarek Hegazi
Journal:  BMC Musculoskelet Disord       Date:  2020-01-08       Impact factor: 2.362

5.  Atlas of non-pathological solitary or asymmetrical skeletal muscle uptake in [18F]FDG-PET.

Authors:  Tomohiko Yamane; Yohji Matsusaka; Kenji Fukushima; Akira Seto; Ichiro Matsunari; Ichiei Kuji
Journal:  Jpn J Radiol       Date:  2022-03-28       Impact factor: 2.701

6.  Painful elastofibroma dorsi: a report of a case and a brief review of the literature.

Authors:  Evangelos Falidas; Dimitrios Arvanitis; Georgios Anyfantakis; Angelos Pazidis; Zacharoula Koukouli; Dimosthenis Miltiadou; Anastasia Koronaiou
Journal:  Case Rep Orthop       Date:  2013-01-14

7.  Elastofibroma: clinical results after resection of a rare tumor entity.

Authors:  Hakan Pilge; Tobias Hesper; Boris Michael Holzapfel; Peter Michael Prodinger; Melanie Straub; Rüdiger Krauspe
Journal:  Orthop Rev (Pavia)       Date:  2014-06-16

8.  Unusual Presentation of Elastofibroma Dorsi on 18F-FDG-PET/CT: A Case Report.

Authors:  Steve P Martin; Joanna Gariani; Claire Tabouret Viaud
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.